DIA
IMMU

Denver Investment Advisors’s Immunomedics Inc IMMU Stock Holding History

Denver Investment Advisors’s Portfolio IMMU Stock Details IMMU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-52,616
Closed -$253K – 674
2014
Q4 		$253K Buy
52,616
+220
+0.4% +$870 0.01% 508
2014
Q3 		$195K Buy
52,396
+2,959
+6% +$10K 0.01% 542
2014
Q2 		$180K Buy
49,437
+24,976
+102% +$91.7K 0.01% 562
2014
Q1 		$103K Buy
+24,461
New +$121K ﹤0.01% 598

Other funds holding IMMU

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Denver Investment Advisors's IMMU Position: Q1 2015 in Review

Denver Investment Advisors sold out of Immunomedics Inc (IMMU) in Q1 2015, closing a stake of 52,616 shares — an estimated $253K sold.

Denver Investment Advisors first reported a position in IMMU in Q1 2014 and held it in 4 quarters. The position peaked at $253K in Q4 2014. 86 funds tracked by Wall St. Rank hold IMMU as of Q1 2015.

  • Denver Investment Advisors reported no remaining Immunomedics Inc position as of Q1 2015 after selling out during the quarter.
  • Denver Investment Advisors sold 52,616 Immunomedics Inc shares in Q1 2015, an estimated $253K.
  • Denver Investment Advisors first reported a position in Immunomedics Inc in Q1 2014 and held it in 4 quarters.
  • Denver Investment Advisors's Immunomedics Inc position peaked at $253K in Q4 2014.
  • 86 funds tracked by Wall St. Rank held Immunomedics Inc as of Q1 2015.

Based on Denver Investment Advisors's 13F filing for Q1 2015, filed 14 May 2015.